You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API atazanavir and cobicistat

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing atazanavir and cobicistat

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
ER Squibb & Sons LLC	EVOTAZ	atazanavir and cobicistat	0003-3641	CELLULOSE, MICROCRYSTALLINE	2032-10-06
ER Squibb & Sons LLC	EVOTAZ	atazanavir and cobicistat	0003-3641	CROSCARMELLOSE SODIUM	2032-10-06
ER Squibb & Sons LLC	EVOTAZ	atazanavir and cobicistat	0003-3641	CROSPOVIDONE	2032-10-06
ER Squibb & Sons LLC	EVOTAZ	atazanavir and cobicistat	0003-3641	HYDROXYPROPYL CELLULOSE	2032-10-06
ER Squibb & Sons LLC	EVOTAZ	atazanavir and cobicistat	0003-3641	MAGNESIUM STEARATE	2032-10-06
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for atazanavir and cobicistat

Excipient focus: CELLULOSE, MICROCRYSTALLINE

atazanavir and cobicistat drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

atazanavir and cobicistat drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

atazanavir and cobicistat drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

atazanavir and cobicistat drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

atazanavir and cobicistat drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

atazanavir and cobicistat drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

atazanavir and cobicistat drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STEARIC ACID

atazanavir and cobicistat drug variants containing STEARIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
ER Squibb & Sons LLC	atazanavir and cobicistat	0003-3641
>Company	>Ingredient	>NDC

atazanavir and cobicistat drug variants not containing STEARIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.